Literature DB >> 23764359

14-Deoxyandrographolide targets adenylate cyclase and prevents ethanol-induced liver injury through constitutive NOS dependent reduced redox signaling in rats.

Samir Mandal1, Vinod K Nelson, Sibabrata Mukhopadhyay, Sukdeb Bandhopadhyay, Lakshmi Maganti, Nanda Ghoshal, Gargi Sen, Tuli Biswas.   

Abstract

Chronic alcoholism is one of the most common causes of liver diseases worldwide. Nitric oxide (NO) has been proposed to have potential for clinical application against chronic hepatocellular injuries. However, mechanisms underlying hepatoprotective functions of NO in ethanol-induced apoptosis are largely unknown. Sprauge-Dawley rats were exposed to ethanol for 8 weeks. Half of the ethanol-fed animals received 14-deoxyandrographolide (14-DAG) treatment for the last 4 weeks of study. Preventive effect of 14-DAG against ethanol-induced hepatotoxicity involved constitutive nitric oxide synthase (cNOS) activation followed by up-regulation of γ-glutamylcysteine synthetase activity and reduced oxidative stress. Enhanced interaction of cNOS with caveolin-1 caused down-regulation of enzyme activity and led to depletion of NO in the hepatocytes of ethanol-fed animals. 14-DAG acted as activator of adenylate cyclase and modulated cyclic AMP (cAMP) mediated expression of caveolin-1 and calmodulin. This eventually favored activation of cNOS through inhibition of cNOS-caveolin-1 interaction. Our results suggest that, protective effect of 14-DAG against ethanol-induced hepatic injury is based on its ability to reduce oxidative stress through cNOS dependent improvement of redox status. 14-DAG mediated activation of adenylate cyclase-cAMP signaling leading to up-regulation of cNOS may provide a promising approach in the prevention of liver diseases during chronic alcoholism.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  14-Deoxyandrographolide; Adenylate cyclase; Chronic alcoholism; Constitutive nitric oxide synthase; Hepatotoxicity; γ-Glutamylcysteine synthetase

Mesh:

Substances:

Year:  2013        PMID: 23764359     DOI: 10.1016/j.fct.2013.05.056

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  7 in total

Review 1.  Role of cAMP and phosphodiesterase signaling in liver health and disease.

Authors:  Banrida Wahlang; Craig McClain; Shirish Barve; Leila Gobejishvili
Journal:  Cell Signal       Date:  2018-06-11       Impact factor: 4.315

2.  A novel antioxidant multitarget iron chelator M30 protects hepatocytes against ethanol-induced injury.

Authors:  Jia Xiao; Yi Lv; Bin Lin; George L Tipoe; Moussa B H Youdim; Feiyue Xing; Yingxia Liu
Journal:  Oxid Med Cell Longev       Date:  2015-02-04       Impact factor: 6.543

3.  Cilostazol protects hepatocytes against alcohol-induced apoptosis via activation of AMPK pathway.

Authors:  Youn Ju Lee; Mi-Sun Shu; Jong-Yeon Kim; Yun-Hye Kim; Kyeong Hwa Sim; Woo Jung Sung; Jong Ryeol Eun
Journal:  PLoS One       Date:  2019-01-29       Impact factor: 3.240

4.  Andrographis Paniculata and Its Bioactive Diterpenoids Protect Dermal Fibroblasts Against Inflammation and Oxidative Stress.

Authors:  Eugenie Mussard; Sundy Jousselin; Annabelle Cesaro; Brigitte Legrain; Eric Lespessailles; Eric Esteve; Sabine Berteina-Raboin; Hechmi Toumi
Journal:  Antioxidants (Basel)       Date:  2020-05-15

5.  Andrographis paniculata leaf extract prevents thioacetamide-induced liver cirrhosis in rats.

Authors:  Daleya Abdulaziz Bardi; Mohammed Farouq Halabi; Pouya Hassandarvish; Elham Rouhollahi; Mohammadjavad Paydar; Soheil Zorofchian Moghadamtousi; Nahla Saeed Al-Wajeeh; Abdulwali Ablat; Nor Azizan Abdullah; Mahmood Ameen Abdulla
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

Review 6.  cAMP Signaling in Pathobiology of Alcohol Associated Liver Disease.

Authors:  Mohamed Elnagdy; Shirish Barve; Craig McClain; Leila Gobejishvili
Journal:  Biomolecules       Date:  2020-10-11

Review 7.  Cyclic AMP Signaling in Biliary Proliferation: A Possible Target for Cholangiocarcinoma Treatment?

Authors:  Leonardo Baiocchi; Ilaria Lenci; Martina Milana; Lindsey Kennedy; Keisaku Sato; Wenjun Zhang; Burcin Ekser; Ludovica Ceci; Vik Meadows; Shannon Glaser; Gianfranco Alpini; Heather Francis
Journal:  Cells       Date:  2021-07-04       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.